Bone Marrow Transplant Team Completes 1st Allogenic Transplant
The UC Health George L. Strike Bone Marrow Transplant Center located in the Hoxworth Building on UCs campus completed its first allogeneic stem cell transplant on Wednesday, Dec. 11.
"Our team is very excited to have reached this milestone, says Elias Anaissie, MD, director of the Hematologic Malignancy and Bone Marrow Transplant Program and John & Gladys Strauss Endowed Chair in Cancer Research at UC. "It represents another step on our way to becoming patients preferred choice for all types of hematologic malignancy care.
Allogeneic stem cell transplantation involves the receipt of bone marrow or blood stem cells from a tissue-matched (HLA-matched) donor who is often a relative of the patient. Allogeneic stem cell transplantation is an inpatient procedure requiring a post-transplant hospital stay while blood cell counts recover.
In the past month, the center also achieved its first outpatient autologous bone marrow transplant and was awarded accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT). FACT accredits hospitals and medical institutions that meet the most rigorous standards when offering therapies that use adult stem cells for patients with blood cancers and diseases.
Tags
Related Stories
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.
On-site training in Speech & Hearing Clinic sets UC’s programs apart
August 27, 2026
At the University of Cincinnati’s Speech & Hearing Clinic, Doctor of Audiology and Speech-Language Pathology graduate students gain real-world experience while providing free speech and hearing services to the community.
Funding expands UC research into weight gain side effects of bipolar medication
August 26, 2026
University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.